SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics ($CAPR) is trending following positive Phase 3 trial results for its DMD treatment, which has excited the community due to the potential for significant improvement in muscle and heart function. Discussions highlight the possibility of a short squeeze and a potential acquisition, with some traders setting ambitious price targets. The focus remains on the implications of the trial's success and potential market impact, particularly regarding those shorting the stock.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), Global Services (BGS), and Boeing Capital (BCC). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The Boeing Capital segment seeks to ensure that Boeing customers have the financing they need to buy and take delivery of their Boeing product and manages overall financing exposure. The company was founded by William Edward Boeing on July 15, 1916 and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing ($BA) is trending as investors digest news of the company's CFO projecting positive free cash flow by 2026 and increased jet deliveries. Community members are actively debating whether this news justifies the recent price surge, with some expressing skepticism and others anticipating a continued rally towards higher price targets. Discussions also involve the impact of new defense contracts and production improvements.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending as the community debates the stock's recent surge, with discussions around potential market manipulation and short squeezes fueled by out-of-the-money call options. Some traders point to analyst upgrades and potential S&P 500 inclusion while others highlight concerns around the company's fundamentals and high short interest. The stock's unusual price action and high valuation relative to peers remain key talking points.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as the community discusses the potential impact of Marvell's acquisition of Celestial AI, a company that relies on POET's optical interposer technology. Investors are speculating about increased demand for POET's products and potential acquisition offers, while also pointing to strong cash reserves and its role in enabling next-generation AI infrastructure. Some are closely watching for news of purchase orders and partnerships that could further validate the company's prospects.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending as the community analyzes recent price action and upcoming earnings, with discussions focusing on potential resistance levels and future growth catalysts. Bullish sentiment appears to be building, driven by optimism surrounding AI infrastructure and data center revenue, and target price increases. Some traders are cautious, noting the stock's historical volatility around earnings and recent analyst ratings.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics ($SERV) is trending amid community excitement surrounding its growth potential in the robotics sector, spurred by upcoming earnings and its partnerships with Uber Eats and DoorDash. Discussions highlight anticipation for the company to deploy 2,000 robots by the end of the year and achieve substantial revenue growth in 2026, with some traders noting potential government support for the robotics industry as a further catalyst. The stock is viewed by some as undervalued with considerable long-term potential, while others express concerns about recent price volatility.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending amid discussions about AI sales targets and the competitive landscape with companies like Google. The community is debating the validity of news reports impacting the stock and whether recent price movements are indicative of manipulation or a buying opportunity. Broader discussions include the company's AI strategy, potential partnerships, and comparisons to competitors like Palantir.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending as the community anticipates FDA feedback on submitted data for belapectin by year-end, potentially influencing the drug's future. Community sentiment is largely positive, with many expressing confidence in the science and speculating about a potential buyout or partnership. Investors are actively monitoring short positions and institutional activity, suggesting anticipation of a significant market move.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors discuss a potential breakout leading up to the upcoming earnings report, with some highlighting a large purchase of shares and speculating about the buyer. Community members are debating the significance of the recent volume and its impact on price movement, while others are focusing on warrant activity. Many continue to express strong conviction in the stock's long-term potential.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending as investors discuss the potential impact of Tonmya's sales and pipeline development, specifically a possible "tsunami" in 2026. Community members are weighing the company's assets, cash position, and potential buyout offers, noting buyback activity and a possible announcement on the horizon. Some traders believe there is potential for a short squeeze, while others express concerns over dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. The company was founded by Carl W. Cotman, Wayne Pambianchi and Gary S. Lynch on February 10, 1987 and is headquartered in Glen Rock, NJ.

Current Price	$0.0018
Prev Close	$0.0018
Open	$0.0018
Dividend Yield	N/A
50-Day Moving Average	$0.0015
Beta	1.80
Avg. Volume	5,406.84
PE Ratio	N/A

52-Week High	$0.0027
52-Week Low	$0.0001
Market Capitalization	$657,754.00
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

RSPI
Respirerx Pharmaceuticals Inc

Feed

News

Sentiment

Fundamentals

Info

Latest RSPI News

RSPIRespirerx Pharmaceuticals Inc